EU Regulator Eyes Mid-September For Decision On Comirnaty BA.4/BA.5 Booster Approval
Agency Also Expects Adapted Spikevax Filing From Moderna This Month
Executive Summary
As regulators continue to process and approve applications for new kinds of COVID-19 booster vaccines, evidence is still awaited on the real-world benefits conferred by the latest variant-adapted products. The European Medicines Agency and the European Centre for Disease Prevention and Control plan to issue a joint statement on the use of adapted vaccines next week, and the EMA has OKd a booster version of the Novavax vaccine.